Published in J Infect Dis on June 26, 2001
How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet (2005) 5.79
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med (2005) 2.15
Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol (2011) 1.97
Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet (2008) 1.57
Flavohemoglobin Hmp protects Salmonella enterica serovar typhimurium from nitric oxide-related killing by human macrophages. Infect Immun (2002) 1.53
History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon. Wien Klin Wochenschr (2007) 1.52
Inflammation and oxidative stress in vertebrate host-parasite systems. Philos Trans R Soc Lond B Biol Sci (2009) 1.46
Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun (2004) 1.35
Increased pulmonary pressures and myocardial wall stress in children with severe malaria. J Infect Dis (2010) 1.33
Genetic polymorphisms linked to susceptibility to malaria. Malar J (2011) 1.29
Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis (2008) 1.27
Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol (2003) 1.23
Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS One (2008) 1.20
NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet (2009) 1.10
Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials (2011) 1.06
Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum (2008) 1.05
Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Hum Genet (2003) 1.00
Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J (2005) 0.99
The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol (2006) 0.98
Malarial hemozoin: from target to tool. Biochim Biophys Acta (2014) 0.96
Stressor-induced increase in microbicidal activity of splenic macrophages is dependent upon peroxynitrite production. Infect Immun (2012) 0.95
Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics (2002) 0.94
Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations. J Clin Invest (2002) 0.91
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J (2008) 0.91
Suppression of erythroid development in vitro by Plasmodium vivax. Malar J (2012) 0.89
Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale. Med Hypotheses (2011) 0.89
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis. Genes Immun (2008) 0.82
The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection. Parasitol Res (2009) 0.82
Analysis of inducible nitric oxide synthase gene polymorphisms in vitiligo in Han Chinese people. PLoS One (2011) 0.82
Role of the lipoperoxidation product 4-hydroxynonenal in the pathogenesis of severe malaria anemia and malaria immunodepression. Oxid Med Cell Longev (2015) 0.81
A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults. Malar J (2010) 0.81
Gastric cancer is associated with NOS2 -954G/C polymorphism and environmental factors in a Brazilian population. BMC Gastroenterol (2010) 0.80
No association of IFNG+874T/A SNP and NOS2A-954G/C SNP variants with nitric oxide radical serum levels or susceptibility to tuberculosis in a Brazilian population subset. Biomed Res Int (2013) 0.80
A globally occurring indel polymorphism in the promoter of the IFNA2 gene is not associated with severity of malaria but with the positivity rate of HCV. BMC Genet (2008) 0.80
IL10A genotypic association with decreased IL-10 circulating levels in malaria infected individuals from endemic area of the Brazilian Amazon. Malar J (2015) 0.79
Relationship of bovine NOS2 gene polymorphisms to the risk of bovine tuberculosis in Holstein cattle. J Vet Med Sci (2015) 0.78
Hemozoin inhibition and control of clinical malaria. Adv Pharmacol Sci (2014) 0.78
NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection, and cerebral malaria. Infect Immun (2013) 0.78
Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study. Malar J (2014) 0.78
Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality. Hum Genet (2012) 0.78
Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase. Clin Mol Hepatol (2015) 0.78
Polymorphisms in host genes encoding NOSII, C-reactive protein, and adhesion molecules thrombospondin and E-selectin are risk factors for Plasmodium falciparum malaria in India. Eur J Clin Microbiol Infect Dis (2015) 0.77
A non-synonymous SNP in the NOS2 associated with septic shock in patients with sepsis in Chinese populations. Hum Genet (2012) 0.77
The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management. Ther Clin Risk Manag (2015) 0.75
Tropical medicine at the University of Tübingen. Wien Klin Wochenschr (2010) 0.75
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet (2002) 4.47
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet (2000) 4.32
Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature (1966) 4.29
Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg (2001) 3.44
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Macrophage tumor killing: influence of the local environment. Science (1977) 2.94
Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med (1996) 2.75
Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol (1978) 2.65
Transmission and passage of experimenal "kuru" to chimpanzees. Science (1967) 2.64
Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors. Lancet (1969) 2.53
Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg (2001) 2.34
The prevalence of gut translocation in humans. Gastroenterology (1994) 2.32
In vitro studies of complement function in sera of C4-deficient guinea pigs. J Exp Med (1971) 2.29
Comparative audit of colorectal resection with the POSSUM scoring system. Br J Surg (1994) 2.28
The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. J Cell Biol (1994) 2.26
Enhanced production of reactive nitrogen intermediates in human and murine malaria. Parasitol Today (1995) 2.18
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum. Proc Natl Acad Sci U S A (2007) 2.14
Standardization and control of meningococcal vaccines, group A and group C polysaccharides. J Biol Stand (1977) 2.11
Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet (1997) 2.10
Improved outcomes with endovascular stent grafts for thoracic aorta transections. Eur J Vasc Endovasc Surg (2008) 2.06
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature (1987) 2.02
Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions. Trans R Soc Trop Med Hyg (1999) 2.02
No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection. Trans R Soc Trop Med Hyg (1999) 2.01
High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM (2004) 2.00
Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am J Trop Med Hyg (1995) 1.96
Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis (1999) 1.96
No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg (1998) 1.96
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. J Antimicrob Chemother (2000) 1.95
Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun (2000) 1.94
Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg (1998) 1.91
Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis (2000) 1.90
Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90
Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal. Trans R Soc Trop Med Hyg (1997) 1.90
Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis (1996) 1.87
Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med (2000) 1.87
Randomized trial of drainage of colorectal anastomosis. Br J Surg (1993) 1.87
Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop Med Parasitol (1995) 1.85
CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med (1996) 1.83
Synthesis of an ovalbumin-like protein by Escherichia coli K12 harbouring a recombinant plasmid. Nature (1978) 1.82
Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors. Lancet (1971) 1.82
National health insurance coverage and socio-economic status in a rural district of Ghana. Trop Med Int Health (2009) 1.81
Regulating immunity to malaria. Parasite Immunol (2006) 1.81
Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Trans R Soc Trop Med Hyg (1998) 1.80
High-molecular-weight protein 2 of Yersinia enterocolitica is homologous to AngR of Vibrio anguillarum and belongs to a family of proteins involved in nonribosomal peptide synthesis. J Bacteriol (1993) 1.79
Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am J Trop Med Hyg (1996) 1.76
Recombinant human gamma-interferon induces human monocyte polykaryon formation. Proc Natl Acad Sci U S A (1984) 1.72
Plasmodium falciparum parasites in French Guiana: limited genetic diversity and high selfing rate. Am J Trop Med Hyg (1999) 1.68
Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein. Infect Immun (1994) 1.67
Molecular cloning, iron-regulation and mutagenesis of the irp2 gene encoding HMWP2, a protein specific for the highly pathogenic Yersinia. Mol Microbiol (1992) 1.66
Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum (2001) 1.66
Hearing conservation for farmers: source apportionment of occupational and environmental factors contributing to hearing loss. J Occup Environ Med (2000) 1.66
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet (1998) 1.65
Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis (2000) 1.64
Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Clin Infect Dis (1998) 1.64
Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Trans R Soc Trop Med Hyg (2001) 1.63
The gene coding for the 190,000-dalton iron-regulated protein of Yersinia species is present only in the highly pathogenic strains. Infect Immun (1989) 1.62
The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis (1999) 1.62
Duodenal obstruction by gallstones (Bouveret's syndrome): a review of the literature. Endoscopy (2005) 1.62
PCR typing of field isolates of Plasmodium falciparum. J Clin Microbiol (1995) 1.61
Malaria: how useful are clinical criteria for improving the diagnosis in a highly endemic area? Trans R Soc Trop Med Hyg (1995) 1.61
Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Am J Trop Med Hyg (1996) 1.60
The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite. Cell Microbiol (2000) 1.58
Endocytosis of red blood cells or haemoglobin by activated macrophages inhibits their tumoricidal effect. Nature (1977) 1.55
Serum transferrin receptor levels are increased in asymptomatic and mild Plasmodium falciparum-infection. Haematologica (1999) 1.50
Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: classification, incidence, diagnosis, and management. J Endovasc Surg (1997) 1.49
Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Infect Immun (2000) 1.49
Pathogenesis of reovirus type 1 hydrocephalus in mice. Significance of aqueductal changes. Arch Neurol (1977) 1.49
Atopy and malaria. Wien Klin Wochenschr (2001) 1.48
Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. Clin Exp Immunol (2002) 1.48
Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration. Arthritis Res Ther (2011) 1.47
The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol (2001) 1.47
Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood (1992) 1.47
Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area. Parasitology (1994) 1.46
Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet (1996) 1.46
Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity. Southeast Asian J Trop Med Public Health (1980) 1.46
Malaria in Central Europe: fears and facts. Wien Klin Wochenschr (2000) 1.44
Endoleak--a proposed new terminology to describe incomplete aneurysm exclusion by an endoluminal graft. J Endovasc Surg (1996) 1.44
Nitric oxide and cerebral malaria. Lancet (1993) 1.43
Saphenous-vein arteriovenous fistula in regular dialysis treatment. N Engl J Med (1969) 1.42
Differential targeting of dense granule proteins in the parasitophorous vacuole of Toxoplasma gondii. Parasitology (1991) 1.41
Experimental "kuru" in chimpanzees. A pathological report. Lancet (1966) 1.40
Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother (1995) 1.40
Bias in interpretation of ambiguous sentences related to threat in anxiety. J Abnorm Psychol (1991) 1.39
Tuberculosis management practices in Kentucky: comparison with national guidelines. South Med J (1999) 1.39
Association of severe malaria with a specific Plasmodium falciparum genotype in French Guiana. J Infect Dis (2001) 1.39
Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp Parasitol (2001) 1.38
Translocation of enteric bacteria in humans. Br J Surg (1993) 1.38
Model experiments for the study of iron transfer from transferrin to ferritin. Eur J Biochem (1969) 1.38
Nalbuphine reversal of respiratory depression after epidural sufentanil. Crit Care Med (1989) 1.38
The effects of static and intermittent compression on nitric oxide production in articular cartilage explants. J Orthop Res (2001) 1.38